Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2015
Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy.
Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 40 citations in OpenAlex.
- Associations Among Sleep Latency, Subjective Pain, and Thermal Pain Sensitivity in Gynecologic Cancer.Pain medicine (Malden, Mass.) · 2020Trial
- Effect of a patient-tailored integrative medicine program on gastro-intestinal concerns and quality of life in patients with breast and gynecologic cancer.Journal of cancer research and clinical oncology · 2017Trial
- A Qualitative Analysis of Cancer Patients' Perceptions of an Interprofessional Counseling Service on Complementary and Integrative Healthcare.Qualitative health research · 2024Article
- Identifying cultural, demographic, personal health and cancer-related barriers to integrative oncology care: a retrospective case-cohort study.Journal of cancer research and clinical oncology · 2023Article
- Integrative Medicine for Ovarian Cancer.Current oncology reports · 2023Review
- Utilization of complementary and alternative medicine (CAM) by women with breast cancer or gynecological cancer.PloS one · 2023Article
- Can integrative oncology increase adherence to chemotherapy in advanced gynecologic cancer?Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Article
- Correlation between an integrative oncology treatment program and survival in patients with advanced gynecological cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021Article
- Article
- Inverse relationship between reduced fatigue and severity of anemia in oncology patients treated with integrative medicine: understanding the paradox.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018Article
- Article
- Providing integrative care in the pre-chemotherapy setting: a pragmatic controlled patient-centered trial with implications for supportive cancer care.Journal of cancer research and clinical oncology · 2018Article
- Self-reported Improvement in Side Effects and Quality of Life With Integrative Medicine in Breast Cancer Patients.Integrative cancer therapies · 2018Article
- Impact of a complementary/integrative medicine program on the need for supportive cancer care-related medications.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017Article
- Effect of a 12-week integrative oncology intervention on gastro-intestinal concerns in patients with gynecological and breast cancer undergoing chemotherapy.Medical oncology (Northwood, London, England) · 2017Article
- Using a Whole Person Approach to Support People With Cancer: A Longitudinal, Mixed-Methods Service Evaluation.Integrative cancer therapies · 2016Article
- Quality of life-related outcomes from a patient-tailored integrative medicine program: experience of Russian-speaking patients with cancer in Israel.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016Article
- Designing an integrative gynecologic oncology model of supportive care: call for a cross-cultural international collaboration.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016Article
- Integrative medicine, quality of life and gynecological cancer : Comments on the article titled "Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy".Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016Article
- "Doing My Part in My Healing": A Qualitative Study Exploring Integrative Oncology Practices Among African Americans with Cancer.Global advances in integrative medicine and healthArticle
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveIntegrative oncology incorporates complementary medicine (CM) therapies in patients with cancer. We explored the impact of an integrative oncology therapeutic regimen on quality-of-life (QOL) outcomes in women with gynecological cancer undergoing chemotherapy. PATIENTS AND
methodsA prospective preference study examined patients referred by oncology health care practitioners (HCPs) to an integrative physician (IP) consultation and CM treatments. QOL and chemotherapy-related toxicities were evaluated using the Edmonton Symptom Assessment Scale (ESAS) and Measure Yourself Concerns and Wellbeing (MYCAW) questionnaire, at baseline and at a 6-12-week follow-up assessment. Adherence to the integrative care (AIC) program was defined as ≥ 4 CM treatments, with ≤ 30 days between each session.
resultsOf 128 patients referred by their HCP, 102 underwent IP consultation and subsequent CM treatments. The main concerns expressed by patients were fatigue (79.8%), gastrointestinal symptoms (64.6%), pain and neuropathy (54.5 %), and emotional distress (45.5%). Patients in both AIC (n = 68) and non-AIC (n = 28) groups shared similar demographic, treatment, and cancer-related characteristics. ESAS fatigue scores improved by a mean of 1.97 points in the AIC group on a scale of 0-10 and worsened by a mean of 0.27 points in the non-AIC group (p = 0.033). In the AIC group, MYCAW scores improved significantly (p < 0.0001) for each of the leading concerns as well as for well-being, a finding which was not apparent in the non-AIC group.
conclusionsAn IP-guided CM treatment regimen provided to patients with gynecological cancer during chemotherapy may reduce cancer-related fatigue and improve other QOL outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.